Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Murphy, R; Driscoll, P; O'Driscoll, R
   Emergency oxygen therapy for the COPD patient
   EMERGENCY MEDICINE JOURNAL
   
   R. Murphy et al., "Emergency oxygen therapy for the COPD patient", EMERG MED J, 18(5), 2001, pp. 333-339
2. Crane, SD; Gray, AJ; Elliott, MW
   The role of non-invasive ventilation in the emergency department
   EMERGENCY MEDICINE JOURNAL
   
   S.D. Crane et al., "The role of non-invasive ventilation in the emergency department", EMERG MED J, 18(5), 2001, pp. 413-414
3. Chevrolet, JC
   Helium oxygen mixtures in the intensive care unit
   CRITICAL CARE
   
   J.C. Chevrolet, "Helium oxygen mixtures in the intensive care unit", CRIT CARE, 5(4), 2001, pp. 179-181
4. Pauwels, R
   Current therapy for COPD
   NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
   
   R. Pauwels, "Current therapy for COPD", PROG R RES, 31, 2001, pp. 11-14
5. Peuskens, J; De Hert, M; Jones, M
   The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety
   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
   
   J. Peuskens et al., "The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety", INT J PSYC, 5(3), 2001, pp. 179-187
6. Blondeau, JM
   Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   J.M. Blondeau, "Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections", EXPERT OP I, 10(2), 2001, pp. 213-237
7. Yassin, HM; Dever, LL
   Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   H.M. Yassin e L.L. Dever, "Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections", EXPERT OP I, 10(2), 2001, pp. 353-367
8. Jacobs, MR
   Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters
   CLINICAL MICROBIOLOGY AND INFECTION
   
   M.R. Jacobs, "Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters", CL MICRO IN, 7(11), 2001, pp. 589-596
9. Ruchlin, HS; Dasbach, EJ
   An economic overview of chronic obstructive pulmonary disease
   PHARMACOECONOMICS
   
   H.S. Ruchlin e E.J. Dasbach, "An economic overview of chronic obstructive pulmonary disease", PHARMACOECO, 19(6), 2001, pp. 623-642
10. Obaji, A; Sethi, S
    Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?
    DRUGS & AGING
    
    A. Obaji e S. Sethi, "Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?", DRUG AGING, 18(1), 2001, pp. 1-11
11. Cazzola, M; Matera, MG; Tufano, MA; Catalanotti, P; Polverino, M; Cantoni, V; Fici, F; Sarlo, F; Rossi, F
    Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study
    JOURNAL OF CHEMOTHERAPY
    
    M. Cazzola et al., "Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study", J CHEMOTHER, 13(4), 2001, pp. 407-412
12. Ball, P; Wilson, R; Mandell, L; Brown, J; Henkel, T
    Efficacy of gemifloxacin in acute exacerbations of chromic bronchitis: a randomised, double-blind comparison with trovafloxacin
    JOURNAL OF CHEMOTHERAPY
    
    P. Ball et al., "Efficacy of gemifloxacin in acute exacerbations of chromic bronchitis: a randomised, double-blind comparison with trovafloxacin", J CHEMOTHER, 13(3), 2001, pp. 288-298
13. McCarty, JM; Pierce, PF
    Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    J.M. McCarty e P.F. Pierce, "Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis", ANN ALLER A, 87(4), 2001, pp. 327-334
14. Gay, PC; Hess, DR; Hill, NS
    Noninvasive proportional assist ventilation for acute respiratory insufficiency - Comparison with pressure support ventilation
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    P.C. Gay et al., "Noninvasive proportional assist ventilation for acute respiratory insufficiency - Comparison with pressure support ventilation", AM J R CRIT, 164(9), 2001, pp. 1606-1611
15. Carlucci, A; Richard, JC; Wysocki, M; Lepage, E; Brochard, L
    Noninvasive versus conventional mechanical ventilation - An epidemiologic survey
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    A. Carlucci et al., "Noninvasive versus conventional mechanical ventilation - An epidemiologic survey", AM J R CRIT, 163(4), 2001, pp. 874-880
16. Holley, MT; Morrissey, TK; Seaberg, DC; Afessa, B; Wears, RL
    Ethical dilemmas in a randomized trial of asthma treatment: Can Bayesian statistical analysis explain the results?
    ACADEMIC EMERGENCY MEDICINE
    
    M.T. Holley et al., "Ethical dilemmas in a randomized trial of asthma treatment: Can Bayesian statistical analysis explain the results?", ACAD EM MED, 8(12), 2001, pp. 1128-1135
17. Osser, DN; Sigadel, R
    Short-term inpatient pharmacotherapy of schizophrenia
    HARVARD REVIEW OF PSYCHIATRY
    
    D.N. Osser e R. Sigadel, "Short-term inpatient pharmacotherapy of schizophrenia", HARV R PSYC, 9(3), 2001, pp. 89-104
18. Paladino, JA
    Is more than one quinolone needed in clinical practice?
    ANNALS OF PHARMACOTHERAPY
    
    J.A. Paladino, "Is more than one quinolone needed in clinical practice?", ANN PHARMAC, 35(9), 2001, pp. 1085-1095
19. Russo, RL; D'Aprile, M
    Role of antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease
    ANNALS OF PHARMACOTHERAPY
    
    R.L. Russo e M. D'Aprile, "Role of antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease", ANN PHARMAC, 35(5), 2001, pp. 576-581
20. Weiss, K; Restieri, C; Gauthier, R; Laverdiere, M; McGeer, A; Davidson, RJ; Kilburn, L; Bast, DJ; de Azavedo, J; Low, DE
    A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae
    CLINICAL INFECTIOUS DISEASES
    
    K. Weiss et al., "A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae", CLIN INF D, 33(4), 2001, pp. 517-522
21. Low, DE
    Antimicrobial drug use and resistance among respiratory pathogens in the community
    CLINICAL INFECTIOUS DISEASES
    
    D.E. Low, "Antimicrobial drug use and resistance among respiratory pathogens in the community", CLIN INF D, 33, 2001, pp. S206-S213
22. Ho, PL; Tse, WS; Tsang, KWT; Kwok, TK; Ng, TK; Cheng, VCC; Chan, RMT
    Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study
    CLINICAL INFECTIOUS DISEASES
    
    P.L. Ho et al., "Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study", CLIN INF D, 32(5), 2001, pp. 701-707
23. Schentag, JJ; Gilliland, KK; Paladino, JA
    What have we learned from pharmacokinetic and pharmacodynamic theories?
    CLINICAL INFECTIOUS DISEASES
    
    J.J. Schentag et al., "What have we learned from pharmacokinetic and pharmacodynamic theories?", CLIN INF D, 32, 2001, pp. S39-S46
24. Krasemann, C; Meyer, J; Tillotson, G
    Evaluation of the clinical microbiology profile of moxifloxacin
    CLINICAL INFECTIOUS DISEASES
    
    C. Krasemann et al., "Evaluation of the clinical microbiology profile of moxifloxacin", CLIN INF D, 32, 2001, pp. S51-S63
25. FitzGerald, M
    Extracts from "Clinical Evidence" - Acute asthma
    BRITISH MEDICAL JOURNAL
    
    M. FitzGerald, "Extracts from "Clinical Evidence" - Acute asthma", BR MED J, 323(7317), 2001, pp. 841-845
26. Cazzola, M; Blasi, F; Allegra, L
    Critical evaluation of guidelines for the treatment of lower respiratory tract bacterial infections
    RESPIRATORY MEDICINE
    
    M. Cazzola et al., "Critical evaluation of guidelines for the treatment of lower respiratory tract bacterial infections", RESP MED, 95(2), 2001, pp. 95-108
27. Ball, P; File, TM; Twynholm, M; Henkel, T
    Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    P. Ball et al., "Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections", INT J ANT A, 18(1), 2001, pp. 19-27
28. Akalin, HE
    The place of antibiotic therapy in the management of chronic acute exacerbations of chronic bronchitis
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    H.E. Akalin, "The place of antibiotic therapy in the management of chronic acute exacerbations of chronic bronchitis", INT J ANT A, 18, 2001, pp. S49-S55
29. Wysocki, M; Antonelli, M
    Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure
    EUROPEAN RESPIRATORY JOURNAL
    
    M. Wysocki e M. Antonelli, "Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure", EUR RESP J, 18(1), 2001, pp. 209-220
30. Wilson, R
    Bacteria, antibiotics and COPD
    EUROPEAN RESPIRATORY JOURNAL
    
    R. Wilson, "Bacteria, antibiotics and COPD", EUR RESP J, 17(5), 2001, pp. 995-1007
31. Arroliga, AC
    Noninvasive positive pressure ventilation in acute respiratory failure: Does it improve outcomes?
    CLEVELAND CLINIC JOURNAL OF MEDICINE
    
    A.C. Arroliga, "Noninvasive positive pressure ventilation in acute respiratory failure: Does it improve outcomes?", CLEV CLIN J, 68(8), 2001, pp. 677-680
32. 
    Revision of the IVth Consensus Conference on anti-infectious treatments ofFrench Society of Infectious Diseases (SPILF): Management of lower respiratory tract infections
    REVUE DES MALADIES RESPIRATOIRES
    
    REV MAL RES, 18(3), 2001, pp. 337-350
33. Perrin, C; Wolter, P; Berthier, F; Tamisier, R; Jullien, V; Lemoigne, F; Blaive, B
    Comparison of volume preset and pressure preset ventilators during daytimenasal ventilation in chronic respiratory failure
    REVUE DES MALADIES RESPIRATOIRES
    
    C. Perrin et al., "Comparison of volume preset and pressure preset ventilators during daytimenasal ventilation in chronic respiratory failure", REV MAL RES, 18(1), 2001, pp. 41-48
34. Chidiac, C
    Report on bronchitis
    MEDECINE ET MALADIES INFECTIEUSES
    
    C. Chidiac, "Report on bronchitis", MED MAL INF, 31(5), 2001, pp. 302-338
35. 
    Should we use antibiotics to treat acute bronchitis in the healthy adult or acutely exacerbated chronic bronchitis in the patient without respiratorydistress syndrome
    MEDECINE ET MALADIES INFECTIEUSES
    
    MED MAL INF, 31(5), 2001, pp. 339-343
36. 
    Should acute bronchitis in the healthy adult or chronic bronchitis in a non respiratory deficient patient be treated by antibiotherapy? Which molecule should be used? In what type of patient?
    MEDECINE ET MALADIES INFECTIEUSES
    
    MED MAL INF, 31(5), 2001, pp. 352-356
37. Zuck, P
    Non antibiotic management of acute to chronic bronchitis, without considering respiratory insufficiency (non obstructive - and obstructive bronchitis).
    MEDECINE ET MALADIES INFECTIEUSES
    
    P. Zuck, "Non antibiotic management of acute to chronic bronchitis, without considering respiratory insufficiency (non obstructive - and obstructive bronchitis).", MED MAL INF, 31(4), 2001, pp. 195-205
38. Gaillat, J; Dabernat, H
    Reassement of the Lille consensus on treatment of chronic bronchitis exacerbation
    MEDECINE ET MALADIES INFECTIEUSES
    
    J. Gaillat e H. Dabernat, "Reassement of the Lille consensus on treatment of chronic bronchitis exacerbation", MED MAL INF, 31(4), 2001, pp. 211-228
39. Gaillat, J; Baranes, C; Amsellem, D; Cohen, A; Bougon, N; Riebbels, V; Chauveau, E
    Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis.
    MEDECINE ET MALADIES INFECTIEUSES
    
    J. Gaillat et al., "Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis.", MED MAL INF, 31(2), 2001, pp. 52-60
40. Scheirlinckx, K; Vanpee, D; Swine, C
    Non-invasive ventilation for frail elderly patients with acute respiratoryfailure
    AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    
    K. Scheirlinckx et al., "Non-invasive ventilation for frail elderly patients with acute respiratoryfailure", AGING-CLIN, 13(1), 2001, pp. 58-61
41. Jolliet, P; Abajo, B; Pasquina, P; Chevrolet, JC
    Non-invasive pressure support ventilation in severe community-acquired pneumonia
    INTENSIVE CARE MEDICINE
    
    P. Jolliet et al., "Non-invasive pressure support ventilation in severe community-acquired pneumonia", INTEN CAR M, 27(5), 2001, pp. 812-821
42. Nava, S; Karakurt, S; Rampulla, C; Braschi, A; Fanfulla, F
    Salbutamol delivery during non-invasive mechanical ventilation in patientswith chronic obstructive pulmonary disease: a randomized, controlled study
    INTENSIVE CARE MEDICINE
    
    S. Nava et al., "Salbutamol delivery during non-invasive mechanical ventilation in patientswith chronic obstructive pulmonary disease: a randomized, controlled study", INTEN CAR M, 27(10), 2001, pp. 1627-1635
43. Contopoulos-Ioannidis, DG; Ioannidis, JPA; Chew, P; Lau, J
    Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections
    Journal of antimicrobial chemotherapy
    
    D.G. Contopoulos-Ioannidis et al., "Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections", J ANTIMICRO, 48(5), 2001, pp. 691-703
44. Georgopoulos, A; Borek, M; Ridl, W
    Randomized, double-blind, double-dummy study comparing the efficacy and safety of amoxycillin 1 g bd with amoxycillin 500 mg tds in the treatment of acute exacerbations of chronic bronchitis
    Journal of antimicrobial chemotherapy
    
    A. Georgopoulos et al., "Randomized, double-blind, double-dummy study comparing the efficacy and safety of amoxycillin 1 g bd with amoxycillin 500 mg tds in the treatment of acute exacerbations of chronic bronchitis", J ANTIMICRO, 47(1), 2001, pp. 67-76
45. Leis, S; Erbguth, F; Winterholler, M
    Indications and limitations of noninvasive positive pressure ventilation (NPPV) in a neurological intensive care unit
    AKTUELLE NEUROLOGIE
    
    S. Leis et al., "Indications and limitations of noninvasive positive pressure ventilation (NPPV) in a neurological intensive care unit", AKT NEUROL, 28(5), 2001, pp. 228-231
46. Lecrubier, Y; Azorin, M; Bottai, T; Dalery, J; Garreau, G; Lemperiere, T; Lisoprawski, A; Petitjean, F; Vanelle, JM
    Consensus on the practical use of amisulpride, an atypical antipsychotic, in the treatment of schizophrenia
    NEUROPSYCHOBIOLOGY
    
    Y. Lecrubier et al., "Consensus on the practical use of amisulpride, an atypical antipsychotic, in the treatment of schizophrenia", NEUROPSYCHB, 44(1), 2001, pp. 41-46
47. Utset, JM
    Non-invasive ventilation in acute cardiogenic pulmonary edema
    REVISTA ESPANOLA DE CARDIOLOGIA
    
    J.M. Utset, "Non-invasive ventilation in acute cardiogenic pulmonary edema", REV ESP CAR, 54(9), 2001, pp. 1023-1028
48. Anzueto, A; Jardim, JR; Lopez, H; Luna, C; Mazzei, JA; de Oliveira, JCA; Pereira, J; Gonzalez, P; Lisboa, C; Maldonado, D; Torres, C; Selmo, SM; Miravitlles, M; de Castro, FR; Torres, A; Ramirez, J; Luna, JM; Diaz, M; Padilla, RP; Ramirez, A; Sansores, R
    ALAT recommendations on infectious exacerbation of COPD.
    ARCHIVOS DE BRONCONEUMOLOGIA
    
    A. Anzueto et al., "ALAT recommendations on infectious exacerbation of COPD.", ARCH BRONCO, 37(8), 2001, pp. 349-357
49. Marrades, RM; Roisin, RR
    COPD and non invasive ventilation
    ARCHIVOS DE BRONCONEUMOLOGIA
    
    R.M. Marrades e R.R. Roisin, "COPD and non invasive ventilation", ARCH BRONCO, 37(2), 2001, pp. 88-95
50. Jimenez, JDG; Segovia, JS; Carranza, MH; Perez, JAM; Quintero, MC; Garcia, RA
    Non-invasive ventilation: an experimental study comparing parameters of adaptation
    ARCHIVOS DE BRONCONEUMOLOGIA
    
    J.D.G. Jimenez et al., "Non-invasive ventilation: an experimental study comparing parameters of adaptation", ARCH BRONCO, 37(1), 2001, pp. 7-13
51. Landen, H; Moller, M; Tillotson, GS; Kubin, R; Hoffken, G
    Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    H. Landen et al., "Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin", J INT MED R, 29(2), 2001, pp. 51-60
52. Lorenz, J; Busch, W; Thate-Waschke, IM
    Moxifloxacin in acute exacerbations of chronic bronchitis: Clinical evaluation and assessment by patients
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    J. Lorenz et al., "Moxifloxacin in acute exacerbations of chronic bronchitis: Clinical evaluation and assessment by patients", J INT MED R, 29(2), 2001, pp. 61-73
53. Lorenz, J; Thate-Waschke, IM; Mast, O; Kubin, R; Rychlik, R; Pfeil, T; Daniel, D; Tillotson, GS
    Treatment outcomes in acute exacerbations of chronic bronchitis: Comparison of macrolides and moxifloxacin from the patient perspective
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    J. Lorenz et al., "Treatment outcomes in acute exacerbations of chronic bronchitis: Comparison of macrolides and moxifloxacin from the patient perspective", J INT MED R, 29(2), 2001, pp. 74-86
54. Adkison, JD; Konzem, SL
    Management of acute exacerbations of chronic obstructive pulmonary disease
    PHARMACOTHERAPY
    
    J.D. Adkison e S.L. Konzem, "Management of acute exacerbations of chronic obstructive pulmonary disease", PHARMACOTHE, 21(8), 2001, pp. 929-939
55. Fish, DN
    Fluoroquinolone adverse effects and drug interactions
    PHARMACOTHERAPY
    
    D.N. Fish, "Fluoroquinolone adverse effects and drug interactions", PHARMACOTHE, 21(10), 2001, pp. 253S-272S
56. Eccles, M; Rousseau, N; Higgins, B; Thomas, L
    Evidence-based guideline on the primary care management of asthma
    FAMILY PRACTICE
    
    M. Eccles et al., "Evidence-based guideline on the primary care management of asthma", FAM PRACT, 18(2), 2001, pp. 223-229
57. Saint, S; Flaherty, KR; Abrahamse, P; Martinez, FJ; Fendrick, AM
    Acute exacerbation of chronic bronchitis: Disease-specific issues that influence the cost-effectiveness of antimicrobial therapy
    CLINICAL THERAPEUTICS
    
    S. Saint et al., "Acute exacerbation of chronic bronchitis: Disease-specific issues that influence the cost-effectiveness of antimicrobial therapy", CLIN THER, 23(3), 2001, pp. 499-512
58. Fendrick, AM; Saint, S; Brook, I; Jacobs, MR; Pelton, S; Sethi, S
    Diagnosis and treatment of upper respiratory tract infections in the primary care setting
    CLINICAL THERAPEUTICS
    
    A.M. Fendrick et al., "Diagnosis and treatment of upper respiratory tract infections in the primary care setting", CLIN THER, 23(10), 2001, pp. 1683-1706
59. Perfetto, EM; Mullins, CD; Subedi, P; Li-McLeod, J
    Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis
    CLINICAL THERAPEUTICS
    
    E.M. Perfetto et al., "Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis", CLIN THER, 23(10), 2001, pp. 1747-1772
60. Gotfried, MH; DeAbate, CA; Fogarty, C; Mathew, CP; Sokol, WN
    Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis
    CLINICAL THERAPEUTICS
    
    M.H. Gotfried et al., "Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis", CLIN THER, 23(1), 2001, pp. 97-107
61. Nouira, S; Marghli, S; Belghith, M; Besbes, L; Elatrous, S; Abroug, F
    Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial
    LANCET
    
    S. Nouira et al., "Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial", LANCET, 358(9298), 2001, pp. 2020-2025
62. Klepser, ME; Ernst, EJ; Petzold, CR; Rhomberg, P; Doern, GV
    Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M.E. Klepser et al., "Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model", ANTIM AG CH, 45(3), 2001, pp. 673-678
63. Confalonieri, M; Gorini, M; Ambrosino, N; Mollica, C; Corrado, A
    Respiratory intensive care units in Italy: a national census and prospective cohort study
    THORAX
    
    M. Confalonieri et al., "Respiratory intensive care units in Italy: a national census and prospective cohort study", THORAX, 56(5), 2001, pp. 373-378
64. Flaherty, KR; Saint, S; Fendrick, AM; Martinez, FJ
    The spectrum of acute bronchitis - Using baseline factors to guide empirical therapy
    POSTGRADUATE MEDICINE
    
    K.R. Flaherty et al., "The spectrum of acute bronchitis - Using baseline factors to guide empirical therapy", POSTGR MED, 109(2), 2001, pp. 39-47
65. Koehler, U; Greib, C; Holland, A; Schafer, H; von Wichert, P
    Therapeutic options in chronic respiratory distress syndrome
    INTERNIST
    
    U. Koehler et al., "Therapeutic options in chronic respiratory distress syndrome", INTERNIST, 42(3), 2001, pp. 363-372
66. Curran, MP; Perry, CM
    Amisulpride - A review of its use in the management of schizophrenia
    DRUGS
    
    M.P. Curran e C.M. Perry, "Amisulpride - A review of its use in the management of schizophrenia", DRUGS, 61(14), 2001, pp. 2123-2150
67. Hall, CS; Fein, A
    Top ten list in COPD
    CHEST
    
    C.S. Hall e A. Fein, "Top ten list in COPD", CHEST, 120(2), 2001, pp. 652-654
68. Nevins, ML; Epstein, SE
    Predictors of outcome for patients with COPD requiring invasive mechanicalventilation
    CHEST
    
    M.L. Nevins e S.E. Epstein, "Predictors of outcome for patients with COPD requiring invasive mechanicalventilation", CHEST, 119(6), 2001, pp. 1840-1849
69. Chipps, BE; Chipps, DR
    A review of the role of inhaled corticosteroids in the treatment of acute asthma
    CLINICAL PEDIATRICS
    
    B.E. Chipps e D.R. Chipps, "A review of the role of inhaled corticosteroids in the treatment of acute asthma", CLIN PEDIAT, 40(4), 2001, pp. 185-189
70. Tsang, KWT
    Solutions for difficult diagnostic cases of acute exacerbations of chronicbronchitis
    CHEMOTHERAPY
    
    K.W.T. Tsang, "Solutions for difficult diagnostic cases of acute exacerbations of chronicbronchitis", CHEMOTHERA, 47, 2001, pp. 28-38
71. Habib, MP
    Management of clinical failures in non-ICU patients with chronic obstructive pulmonary disease exacerbations
    CHEMOTHERAPY
    
    M.P. Habib, "Management of clinical failures in non-ICU patients with chronic obstructive pulmonary disease exacerbations", CHEMOTHERA, 47, 2001, pp. 39-46
72. Norrby, SR
    Optimal treatment strategies for acute exacerbations of chronic bronchitis: High-risk patients
    CHEMOTHERAPY
    
    S.R. Norrby, "Optimal treatment strategies for acute exacerbations of chronic bronchitis: High-risk patients", CHEMOTHERA, 47, 2001, pp. 47-52
73. Peng, CC; Aspinall, SL; Good, CB
    Update in pulmonary disease
    ANNALS OF INTERNAL MEDICINE
    
    C.C. Peng et al., "Update in pulmonary disease", ANN INT MED, 135(4), 2001, pp. 301-301
74. Antonelli, M; Conti, G
    Noninvasive positive pressure ventilation as treatment for acute respiratory failure in critically ill patients
    CRITICAL CARE
    
    M. Antonelli e G. Conti, "Noninvasive positive pressure ventilation as treatment for acute respiratory failure in critically ill patients", CRIT CARE, 4(1), 2000, pp. 15-22
75. Hart, SP
    Should aminophylline be abandoned in the treatment of acute asthma in adults?
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    S.P. Hart, "Should aminophylline be abandoned in the treatment of acute asthma in adults?", QJM-MON J A, 93(11), 2000, pp. 761-765
76. Jasmer, RM; Matthay, MA
    Noninvasive ventilation for acute respiratory failure
    JOURNAL OF CLINICAL MONITORING AND COMPUTING
    
    R.M. Jasmer e M.A. Matthay, "Noninvasive ventilation for acute respiratory failure", J CLIN M C, 16(5-6), 2000, pp. 403-408
77. Paster, RZ; McAdoo, MA; Keyserling, CH; Nemeth, MA; Tack, KJ; Griffin, TJ
    A comparison of a five-day regimen of cefdinir with a seven-day regimen ofloracarbef for the treatment of acute exacerbations of chronic bronchitis
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    R.Z. Paster et al., "A comparison of a five-day regimen of cefdinir with a seven-day regimen ofloracarbef for the treatment of acute exacerbations of chronic bronchitis", INT J CL PR, 54(5), 2000, pp. 293-299
78. Blondeau, JM
    A review of clinical trials with fluoroquinolones with an emphasis on new agents
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    J.M. Blondeau, "A review of clinical trials with fluoroquinolones with an emphasis on new agents", EXPERT OP I, 9(2), 2000, pp. 383-413
79. Cross, AM
    Review of the role of non-invasive ventilation in the emergency department
    JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    
    A.M. Cross, "Review of the role of non-invasive ventilation in the emergency department", J AC EMER M, 17(2), 2000, pp. 79-85
80. Lader, M
    Rating scales in schizophrenia - A review of their usefulness for assessing atypical antipsychotics
    CNS DRUGS
    
    M. Lader, "Rating scales in schizophrenia - A review of their usefulness for assessing atypical antipsychotics", CNS DRUGS, 14(1), 2000, pp. 23-32
81. Ozminkowski, RJ; Wang, SH; Marder, WD; Azzolini, J; Schutt, D
    Cost implications for the use of inhaled anti-inflammatory medications in the treatment of asthma
    PHARMACOECONOMICS
    
    R.J. Ozminkowski et al., "Cost implications for the use of inhaled anti-inflammatory medications in the treatment of asthma", PHARMACOECO, 18(3), 2000, pp. 253-264
82. File, T; Schlemmer, B; Garau, J; Lode, H; Lynch, S; Young, C
    Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis
    JOURNAL OF CHEMOTHERAPY
    
    T. File et al., "Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis", J CHEMOTHER, 12(4), 2000, pp. 314-325
83. Cazzola, M; Di Perna, F; Boveri, B; Di Marco, F; Diamare, F; Centanni, S
    Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbations of chronic bronchitis
    JOURNAL OF CHEMOTHERAPY
    
    M. Cazzola et al., "Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbations of chronic bronchitis", J CHEMOTHER, 12(3), 2000, pp. 216-222
84. Anzueto, A
    The importance of appropriate treatment of chronic bronchitis
    AMERICAN JOURNAL OF MANAGED CARE
    
    A. Anzueto, "The importance of appropriate treatment of chronic bronchitis", AM J M CARE, 6(8), 2000, pp. S437-S441
85. Kelly, CS; Andersen, CL; Pestian, JP; Wenger, AD; Finch, AB; Strope, GL; Luckstead, EF
    Improved outcomes for hospitalized asthmatic children using a clinical pathway
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    C.S. Kelly et al., "Improved outcomes for hospitalized asthmatic children using a clinical pathway", ANN ALLER A, 84(5), 2000, pp. 509-516
86. Strachan, DP; Carrington, D; Mendall, M; Butland, BK; Yarnell, JWG; Elwood, P
    Chlamydia pneumonia serology, lung function decline, and treatment for respiratory disease
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    D.P. Strachan et al., "Chlamydia pneumonia serology, lung function decline, and treatment for respiratory disease", AM J R CRIT, 161(2), 2000, pp. 493-497
87. Doern, GV
    Antimicrobial resistance with Streptococcus pneumoniae in the United States
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    
    G.V. Doern, "Antimicrobial resistance with Streptococcus pneumoniae in the United States", SEM RESP CR, 21(4), 2000, pp. 273-284
88. Kim, N; Leeper, KV
    Epidemiology of chronic bronchitis and acute infective exacerbations of chronic bronchitis
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    
    N. Kim e K.V. Leeper, "Epidemiology of chronic bronchitis and acute infective exacerbations of chronic bronchitis", SEM RESP CR, 21(2), 2000, pp. 73-78
89. Alghasham, AA; Nahata, MC
    Clinical use of fluoroquinolones in children
    ANNALS OF PHARMACOTHERAPY
    
    A.A. Alghasham e M.C. Nahata, "Clinical use of fluoroquinolones in children", ANN PHARMAC, 34(3), 2000, pp. 347-359
90. Hooper, DC
    New uses for new and old quinolones and the challenge of resistance
    CLINICAL INFECTIOUS DISEASES
    
    D.C. Hooper, "New uses for new and old quinolones and the challenge of resistance", CLIN INF D, 30(2), 2000, pp. 243-254
91. Clementsen, P; Farholt, S; Permin, H; Lange, P; Skov, PS; Norn, S
    Chlamydia pneumoniae and chronic obstructive pulmonary disease: bronchial biopsies (PCR and culture) and specific serum antibodies in patients and controls
    INFLAMMATION RESEARCH
    
    P. Clementsen et al., "Chlamydia pneumoniae and chronic obstructive pulmonary disease: bronchial biopsies (PCR and culture) and specific serum antibodies in patients and controls", INFLAMM RES, 49, 2000, pp. S37-S38
92. Nomori, H; Horio, H; Suemasu, K
    Assisted pressure control ventilation via a mini-tracheostomy tube for postoperative respiratory management of lung cancer patients
    RESPIRATORY MEDICINE
    
    H. Nomori et al., "Assisted pressure control ventilation via a mini-tracheostomy tube for postoperative respiratory management of lung cancer patients", RESP MED, 94(3), 2000, pp. 214-220
93. Lim, TK; Chin, NK; Lee, KH; Stebbings, AM
    Early discharge of patients hospitalized with acute asthma: a controlled study
    RESPIRATORY MEDICINE
    
    T.K. Lim et al., "Early discharge of patients hospitalized with acute asthma: a controlled study", RESP MED, 94(12), 2000, pp. 1234-1240
94. Putinati, S; Ballerin, L; Piattella, M; Panella, GL; Potena, A
    Is it possible to predict the success of non-invasive positive pressure ventilation in acute respiratory failure due to COPD?
    RESPIRATORY MEDICINE
    
    S. Putinati et al., "Is it possible to predict the success of non-invasive positive pressure ventilation in acute respiratory failure due to COPD?", RESP MED, 94(10), 2000, pp. 997-1001
95. Low, DE
    Trends and significance of antimicrobial resistance in respiratory pathogens
    CURRENT OPINION IN INFECTIOUS DISEASES
    
    D.E. Low, "Trends and significance of antimicrobial resistance in respiratory pathogens", CURR OPIN I, 13(2), 2000, pp. 145-153
96. Ball, P
    Acute exacerbations of chronic bronchitis
    CURRENT OPINION IN INFECTIOUS DISEASES
    
    P. Ball, "Acute exacerbations of chronic bronchitis", CURR OPIN I, 13(2), 2000, pp. 171-176
97. Sermet-Gaudelus, I; Ferroni, A; Gaillard, JL; Silly, C; Chretiennot, C; Lenoir, G; Berche, P
    Antibiotic therapy in cystic fibrosis
    ARCHIVES DE PEDIATRIE
    
    I. Sermet-Gaudelus et al., "Antibiotic therapy in cystic fibrosis", ARCH PED, 7(6), 2000, pp. 645-656
98. Carriere, P; Bonhomme, D; Lemperiere, T
    Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group)
    EUROPEAN PSYCHIATRY
    
    P. Carriere et al., "Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group)", EUR PSYCHIA, 15(5), 2000, pp. 321-329
99. Ball, P
    New antibiotics for community-acquired lower respiratory tract infections:improved activity at a cost?
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    P. Ball, "New antibiotics for community-acquired lower respiratory tract infections:improved activity at a cost?", INT J ANT A, 16(3), 2000, pp. 263-272
100. Hammerschlag, MR
     Chlamydia pneumoniae and the lung
     EUROPEAN RESPIRATORY JOURNAL
     
     M.R. Hammerschlag, "Chlamydia pneumoniae and the lung", EUR RESP J, 16(5), 2000, pp. 1001-1007